CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,289,989 | -6.4% | 1,978,365 | +3.6% | 0.01% | 0.0% |
| Q2 2023 | $62,279,136 | +2.0% | 1,909,231 | +10.1% | 0.01% | -12.5% |
| Q1 2023 | $61,043,976 | +80261.2% | 1,734,696 | +4.6% | 0.01% | -27.3% |
| Q4 2022 | $75,962 | -99.9% | 1,657,850 | +4.2% | 0.01% | -8.3% |
| Q3 2022 | $77,106,000 | +32.3% | 1,591,458 | +7.3% | 0.01% | +33.3% |
| Q2 2022 | $58,287,000 | +7.6% | 1,483,522 | +0.8% | 0.01% | +28.6% |
| Q1 2022 | $54,181,000 | -16.8% | 1,471,911 | +3.0% | 0.01% | -12.5% |
| Q4 2021 | $65,116,000 | +30.3% | 1,428,622 | +2.2% | 0.01% | +14.3% |
| Q3 2021 | $49,966,000 | +108.6% | 1,398,048 | +15.5% | 0.01% | +133.3% |
| Q2 2021 | $23,954,000 | -11.1% | 1,210,422 | +4.5% | 0.00% | -25.0% |
| Q1 2021 | $26,938,000 | +22.8% | 1,158,128 | +9.7% | 0.00% | 0.0% |
| Q4 2020 | $21,934,000 | +1.0% | 1,055,561 | +5.2% | 0.00% | 0.0% |
| Q3 2020 | $21,713,000 | +5.8% | 1,002,946 | +15.1% | 0.00% | 0.0% |
| Q2 2020 | $20,531,000 | +103.0% | 871,066 | +1.6% | 0.00% | +33.3% |
| Q1 2020 | $10,112,000 | -40.4% | 857,756 | -46.4% | 0.00% | +50.0% |
| Q4 2019 | $16,974,000 | +88.4% | 1,599,944 | +102.1% | 0.00% | 0.0% |
| Q3 2019 | $9,008,000 | +6.2% | 791,669 | +5.0% | 0.00% | 0.0% |
| Q2 2019 | $8,483,000 | +56.3% | 754,133 | +12.4% | 0.00% | +100.0% |
| Q1 2019 | $5,429,000 | -26.6% | 671,135 | -42.7% | 0.00% | 0.0% |
| Q4 2018 | $7,400,000 | +46.0% | 1,171,086 | +127.6% | 0.00% | 0.0% |
| Q3 2018 | $5,068,000 | +23.0% | 514,589 | +3.7% | 0.00% | 0.0% |
| Q2 2018 | $4,120,000 | +31.8% | 496,450 | +14.4% | 0.00% | 0.0% |
| Q1 2018 | $3,125,000 | -10.5% | 434,120 | +1.3% | 0.00% | 0.0% |
| Q4 2017 | $3,492,000 | -42.9% | 428,548 | +1.6% | 0.00% | -50.0% |
| Q3 2017 | $6,115,000 | +12.7% | 421,735 | -5.9% | 0.00% | 0.0% |
| Q2 2017 | $5,424,000 | +42.3% | 448,276 | +51.1% | 0.00% | 0.0% |
| Q1 2017 | $3,812,000 | +10.1% | 296,683 | +4.1% | 0.00% | 0.0% |
| Q4 2016 | $3,461,000 | +37.8% | 284,936 | +4.1% | 0.00% | +100.0% |
| Q3 2016 | $2,512,000 | -2.6% | 273,668 | +0.7% | 0.00% | 0.0% |
| Q2 2016 | $2,579,000 | +31.2% | 271,851 | -2.5% | 0.00% | 0.0% |
| Q1 2016 | $1,965,000 | -42.4% | 278,830 | -14.5% | 0.00% | -50.0% |
| Q4 2015 | $3,409,000 | +79.2% | 326,080 | +14.7% | 0.00% | +100.0% |
| Q3 2015 | $1,902,000 | +44.1% | 284,313 | +44.7% | 0.00% | 0.0% |
| Q2 2015 | $1,320,000 | -0.2% | 196,478 | +0.7% | 0.00% | 0.0% |
| Q1 2015 | $1,322,000 | +2.2% | 195,076 | +20.7% | 0.00% | 0.0% |
| Q4 2014 | $1,294,000 | +127.8% | 161,642 | +0.1% | 0.00% | – |
| Q3 2014 | $568,000 | -24.9% | 161,411 | +2.0% | 0.00% | – |
| Q2 2014 | $756,000 | -48.8% | 158,323 | +1.8% | 0.00% | -100.0% |
| Q1 2014 | $1,477,000 | +84.9% | 155,547 | +26.5% | 0.00% | 0.0% |
| Q4 2013 | $799,000 | -13.1% | 122,965 | +1.5% | 0.00% | 0.0% |
| Q3 2013 | $919,000 | -13.1% | 121,132 | +32.4% | 0.00% | 0.0% |
| Q2 2013 | $1,058,000 | – | 91,488 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |